308 related articles for article (PubMed ID: 34455985)
1. Prevention and Screening of HPV Malignancies.
Dahlstrom KR; Day AT; Sturgis EM
Semin Radiat Oncol; 2021 Oct; 31(4):297-308. PubMed ID: 34455985
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
4. [Human Papillomavirus: screening of cervical and anal cancers].
Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
[TBL] [Abstract][Full Text] [Related]
5. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease.
Arbyn M; de Sanjosé S; Saraiya M; Sideri M; Palefsky J; Lacey C; Gillison M; Bruni L; Ronco G; Wentzensen N; Brotherton J; Qiao YL; Denny L; Bornstein J; Abramowitz L; Giuliano A; Tommasino M; Monsonego J
Int J Cancer; 2012 Nov; 131(9):1969-82. PubMed ID: 22623137
[TBL] [Abstract][Full Text] [Related]
6. State of the Science: Screening, Surveillance, and Epidemiology of HPV-Related Malignancies.
Ghebre R; Berry-Lawhorn JM; D'Souza G
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-12. PubMed ID: 33830827
[TBL] [Abstract][Full Text] [Related]
7. Trends in Human Papillomavirus-Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017.
Liao CI; Francoeur AA; Kapp DS; Caesar MAP; Huh WK; Chan JK
JAMA Netw Open; 2022 Mar; 5(3):e222530. PubMed ID: 35294540
[TBL] [Abstract][Full Text] [Related]
8. Cancers attributable to human papillomavirus infection.
Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic burden of HPV-related cancers in the US veteran population.
Saxena K; Dawson RS; Cyhaniuk A; Bello T; Janjan N
J Med Econ; 2022; 25(1):299-308. PubMed ID: 35156867
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
[TBL] [Abstract][Full Text] [Related]
11. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
12. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
13. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
Poljak M; Šterbenc A; Lunar MM
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
[TBL] [Abstract][Full Text] [Related]
14. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus and Associated Cancers: A Review.
Jensen JE; Becker GL; Jackson JB; Rysavy MB
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793561
[TBL] [Abstract][Full Text] [Related]
16. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
[TBL] [Abstract][Full Text] [Related]
17. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus: optimizing opportunities for prevention.
Browne S; Feemster KA
Curr Opin Pediatr; 2022 Apr; 34(2):132-139. PubMed ID: 35152231
[TBL] [Abstract][Full Text] [Related]
19. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic.
Schuman A; Anderson KS; Day AT; Ferrell J; Sturgis EM; Dahlstrom KR
Expert Rev Anticancer Ther; 2022 Jul; 22(7):751-761. PubMed ID: 35679626
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers.
Wilkin TJ
Top Antivir Med; 2018 Sep; 26(3):85-88. PubMed ID: 30384331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
